← Leaderboards
Hsian-Rong Tseng
University Of California Los Angeles
$15,333,457
Attributed
$29,999,995
Total exposure
18
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,999,995 · 18
By mechanism
R01$13,131,071 · 5
U01$6,317,570 · 2
R44$3,969,531 · 2
R21$2,556,627 · 6
P01$2,365,879 · 1
R33$1,659,317 · 2
Top collaborators
- Vatche Agopian18 shared
- Edwin Melencio Posadas10 shared
- Sungyong You10 shared
- Yazhen Zhu10 shared
- Sean Xiao Liu5 shared
- Margareta Pisarska5 shared
- Han-Yu Chuang3 shared
- Yan Yang2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Vatche Agopian$3,720,225
- Yazhen Zhu$5,188,074
- Hong Wu$8,515,329
- Sungyong You$3,542,560
- Deborah C Glik$1,052,906
Others in their field
Top investigators on “Microfluidics”
- Richard A Gibbs · Baylor College Of Medicine$91,745,423
- Roger T Howe · University Of California-Berkeley$89,901,072
- Daniel C Ralph · Cornell University$89,901,072
- Mehmet Toner · Massachusetts General Hospital$43,728,700
- Vamsee K Pamula · Advanced Liquid Logic$32,521,508
- Robert B Darnell · Rockefeller University$24,511,943
Research focus
MicrofluidicsDiagnosticCellsSamplingJointsBlood SpecimenBaseMotivationBiometryTumorChemistryTechnologyMonitorPerformanceValidationNeoplasm Circulating CellsSurfaceNanomaterialsMolecularBioinformaticsInnovationBloodMedical CenterExhibits
Grant awards (59)
Translational development of osteosarcoma (OS) extracellular vesicle (EV) matrix metalloproteinase (MMP) Activity Assay for assessing patient treatment responses$2,097,875
R01 · FY2025 · CA · contact PI
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma$661,609
R44 · FY2025 · CA · contact PI
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles$661,505
R01 · FY2025 · CA
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma$748,485
R01 · FY2024 · CA · contact PI
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma$661,609
R44 · FY2024 · CA · contact PI
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles$628,431
R01 · FY2024 · CA
Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection$490,138
R01 · FY2024 · CA
HCC EV Digital Scoring Assay for assessing treatment response in HCC patients$195,726
R01 · FY2024 · CA · contact PI
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts$793,038
U01 · FY2023 · EB · contact PI
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles$674,097
R01 · FY2023 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma$661,609
R44 · FY2023 · CA · contact PI
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma$579,952
R01 · FY2023 · CA · contact PI
Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection$517,033
R01 · FY2023 · CA
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts$793,038
U01 · FY2022 · EB · contact PI
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma$579,952
R01 · FY2022 · CA · contact PI
Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection$553,811
R01 · FY2022 · CA
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts$777,176
U01 · FY2021 · EB · contact PI
A blood test to identify prostate cancer patients at risk for visceral metastasis$601,752
R01 · FY2021 · CA
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma$591,788
R01 · FY2021 · CA · contact PI
Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection$578,057
R01 · FY2021 · CA
Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma$221,408
R21 · FY2021 · CA
Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs$203,580
R21 · FY2021 · CA
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts$793,038
U01 · FY2020 · EB · contact PI
Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection$618,982
R01 · FY2020 · CA
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma$605,790
R01 · FY2020 · CA · contact PI
A blood test to identify prostate cancer patients at risk for visceral metastasis$601,750
R01 · FY2020 · CA
Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma$198,033
R21 · FY2020 · CA
Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs$169,650
R21 · FY2020 · CA
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts$807,038
U01 · FY2019 · EB · contact PI
A blood test to identify prostate cancer patients at risk for visceral metastasis$583,697
R01 · FY2019 · CA
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling$455,920
U01 · FY2019 · CA · contact PI
Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs$169,650
R21 · FY2019 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis$601,750
R01 · FY2018 · CA
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling$470,021
U01 · FY2018 · CA · contact PI
A blood test to identify prostate cancer patients at risk for visceral metastasis$620,500
R01 · FY2017 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA$476,399
P01 · FY2017 · CA · contact PI
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling$470,021
U01 · FY2017 · CA · contact PI
CTC Purification System Based on Thermoresponsive NanoSubstrates$992,352
R44 · FY2016 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA$476,399
P01 · FY2016 · CA · contact PI
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling$471,503
U01 · FY2016 · CA · contact PI
CTC Purification System Based on Thermoresponsive NanoSubstrates$992,352
R44 · FY2015 · CA
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling$486,777
U01 · FY2015 · CA · contact PI
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA$476,399
P01 · FY2015 · CA · contact PI
Molecular and Functional Analysis of Single Circulating Melanoma Cells$331,199
R33 · FY2015 · CA · contact PI
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA$462,107
P01 · FY2014 · CA · contact PI
Molecular and Functional Analysis of Single Circulating Melanoma Cells$322,359
R33 · FY2014 · CA · contact PI
Supramolecular Nanoparticle-Based PET Probes for Pretargeted Tumor Imaging$207,900
R21 · FY2014 · EB · contact PI
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA$474,575
P01 · FY2013 · CA · contact PI
Molecular and Functional Analysis of Single Circulating Melanoma Cells$333,461
R33 · FY2013 · CA · contact PI
Advanced Development of An Integrated CTC Enrichment Technology$218,574
R33 · FY2013 · CA · contact PI
Supramolecular Nanoparticle-Based PET Probes for Pretargeted Tumor Imaging$192,500
R21 · FY2013 · EB · contact PI
Advanced Development of An Integrated CTC Enrichment Technology$228,724
R33 · FY2012 · CA · contact PI
Generation of hPSCs Using Reprogramming Proteins-Encapsulated Nanoparticles$224,400
R21 · FY2012 · GM · contact PI
Advanced Development of An Integrated CTC Enrichment Technology$225,000
R33 · FY2011 · CA · contact PI
3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells$194,941
R21 · FY2011 · CA · contact PI
Generation of hPSCs Using Reprogramming Proteins-Encapsulated Nanoparticles$185,900
R21 · FY2011 · GM · contact PI
Integrated Microfluidic Devices for 18F Labeled PET Probes in Cancer Imaging$228,690
R21 · FY2010 · EB · contact PI
3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells$167,475
R21 · FY2010 · CA · contact PI
Integrated Microfluidic Devices for 18F Labeled PET Probes in Cancer Imaging$192,500
R21 · FY2009 · EB · contact PI